Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ZIOP

Ziopharm

$3.09

0.02 (0.65%)

, BMY

Bristol-Myers

$53.83

0.55 (1.03%)

14:34
11/16/18
11/16
14:34
11/16/18
14:34
Hot Stocks
Ziopharm says 'positive' data from phase 1 trial of Controlled IL-12 presented »

Ziopharm Oncology…

ZIOP

Ziopharm

$3.09

0.02 (0.65%)

BMY

Bristol-Myers

$53.83

0.55 (1.03%)

REGN

Regeneron

$344.82

3.28 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 30

    Nov

  • 02

    Dec

  • 11

    Mar

  • 28

    Apr

  • 13

    May

  • 20

    May

VBLT

VBL Therapeutics

$1.14

-0.04 (-3.39%)

07:30
11/16/18
11/16
07:30
11/16/18
07:30
Hot Stocks
VBL Therapeutics reports results from GLOBE study at SNO »

VBL Therapeutics reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

Yesterday
ZIOP

Ziopharm

$2.95

0.27 (10.07%)

14:31
11/15/18
11/15
14:31
11/15/18
14:31
Upgrade
Ziopharm rating change  »

Ziopharm upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZIOP

Ziopharm

$2.85

0.17 (6.34%)

14:04
11/15/18
11/15
14:04
11/15/18
14:04
Upgrade
Ziopharm rating change at Raymond James »

Ziopharm upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Monday
ZIOP

Ziopharm

$2.53

0.06 (2.43%)

08:54
11/12/18
11/12
08:54
11/12/18
08:54
Syndicate
Ziopharm raises $50M in a private placement »

Ziopharm said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ZIOP

Ziopharm

$2.53

0.06 (2.43%)

, REGN

Regeneron

$356.59

-6.66 (-1.83%)

07:28
11/12/18
11/12
07:28
11/12/18
07:28
Hot Stocks
Ziopharm, Regeneron announce clinical supply agreement for rGBM treatment »

Ziopharm (ZIOP) announced…

ZIOP

Ziopharm

$2.53

0.06 (2.43%)

REGN

Regeneron

$356.59

-6.66 (-1.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 15

    Nov

  • 27

    Nov

  • 11

    Mar

  • 28

    Apr

  • 13

    May

Over a week ago
ZIOP

Ziopharm

$2.49

0.02 (0.81%)

15:34
11/09/18
11/09
15:34
11/09/18
15:34
Options
Ziopharm options imply 16.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ZIOP

Ziopharm

$2.37

0.22 (10.23%)

07:27
11/05/18
11/05
07:27
11/05/18
07:27
Hot Stocks
Ziopharm to announce updated data from Ad-RTS-hIL-12 plus veledimex trial at SNO »

Ziopharm announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

NVCR

Novocure

$34.71

1.55 (4.67%)

05:29
11/02/18
11/02
05:29
11/02/18
05:29
Downgrade
Novocure rating change at Wells Fargo »

Novocure downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVCR

Novocure

$33.55

-7.92 (-19.10%)

05:35
10/26/18
10/26
05:35
10/26/18
05:35
Recommendations
Novocure analyst commentary at Mizuho »

Novocure post-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.